Bingbing Hou
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Kidney Stones and Urolithiasis Treatments
Papers in
-
- Kidney Stones and Urolithiasis Treatments 14
- Renal cell carcinoma treatment 1
-
- Porphyrin Metabolism and Disorders 4
- RNA modifications and cancer 2
- Co-authors
- Zongyao Hao (19 shared papers)Jian‐Hong Zhong (1 shared paper)Haizhou Liu (1 shared paper)Wene Wei (1 shared paper)Xianwei Mo (1 shared paper)Litu Zhang (1 shared paper)Yuxuan Xie (1 shared paper)Jilin Li (1 shared paper)
- Journals
- International Immunopharmacology (4 papers)Urolithiasis (4 papers)Medicine (1 paper)Frontiers in Microbiology (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Bingbing Hou
27 papers receiving 277 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 42
- Pulmonary and Respiratory Medicine 70
- Obstetrics and Gynecology 12
- Molecular Biology 114
- Urology 9
Countries citing papers authored by Bingbing Hou
This map shows the geographic impact of Bingbing Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingbing Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingbing Hou more than expected).
Fields of papers citing papers by Bingbing Hou
This network shows the impact of papers produced by Bingbing Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingbing Hou. The network helps show where Bingbing Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Bingbing Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 81 | |
| 2 | 2023 | 30 | |
| 3 | Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer. | 2019 | 28 |
| 4 | 2023 | 20 | |
| 5 | 2023 | 19 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 12 | |
| 9 | 2023 | 11 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2025 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2024 | 2 |
About Bingbing Hou
Bingbing Hou is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Nephrology, Surgery and Pathology and Forensic Medicine, having authored 30 papers that have together received 280 indexed citations. Recurring topics across this work include Kidney Stones and Urolithiasis Treatments (14 papers), Porphyrin Metabolism and Disorders (4 papers), Biomedical Research and Pathophysiology (3 papers), Pediatric Urology and Nephrology Studies (3 papers), Chronic Kidney Disease and Diabetes (2 papers), RNA modifications and cancer (2 papers), Renal cell carcinoma treatment (1 paper) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Cancer Research (42 citations), Pulmonary and Respiratory Medicine (70 citations), Obstetrics and Gynecology (12 citations), Molecular Biology (114 citations) and Urology (9 citations). Bingbing Hou has collaborated with scholars based in China and United States. Frequent co-authors include Zongyao Hao, Jian‐Hong Zhong, Haizhou Liu, Wene Wei, Xianwei Mo, Litu Zhang, Yuxuan Xie, Jilin Li, Shufang Ning and Jiansi Chen. Their work appears in journals such as International Immunopharmacology, Urolithiasis, Medicine, Frontiers in Microbiology and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.